- Home
- TLSI vs MERC Comparison
TLSI vs MERC Comparison
Compare TLSI & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MERC
- Stock Information
- Founded
- TLSI 2010
- MERC 1968
- Country
- TLSI United States
- MERC Canada
- Employees
- TLSI N/A
- MERC N/A
- Industry
- TLSI Medical Specialities
- MERC Paper
- Sector
- TLSI Health Care
- MERC Basic Materials
- Exchange
- TLSI Nasdaq
- MERC Nasdaq
- Market Cap
- TLSI 244.3M
- MERC 271.5M
- IPO Year
- TLSI N/A
- MERC 1987
- Fundamental
- Price
- TLSI $4.73
- MERC $2.84
- Analyst Decision
- TLSI Strong Buy
- MERC Hold
- Analyst Count
- TLSI 4
- MERC 3
- Target Price
- TLSI $11.13
- MERC $4.67
- AVG Volume (30 Days)
- TLSI 118.6K
- MERC 491.2K
- Earning Date
- TLSI 11-13-2025
- MERC 10-30-2025
- Dividend Yield
- TLSI N/A
- MERC 10.56%
- EPS Growth
- TLSI N/A
- MERC N/A
- EPS
- TLSI N/A
- MERC N/A
- Revenue
- TLSI $35,990,000.00
- MERC $1,951,044,000.00
- Revenue This Year
- TLSI $56.79
- MERC N/A
- Revenue Next Year
- TLSI $54.15
- MERC $13.33
- P/E Ratio
- TLSI N/A
- MERC N/A
- Revenue Growth
- TLSI 45.50
- MERC N/A
- 52 Week Low
- TLSI $3.42
- MERC $2.59
- 52 Week High
- TLSI $5.88
- MERC $8.28
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- MERC 42.57
- Support Level
- TLSI $4.42
- MERC $2.75
- Resistance Level
- TLSI $4.67
- MERC $2.90
- Average True Range (ATR)
- TLSI 0.23
- MERC 0.11
- MACD
- TLSI -0.03
- MERC 0.01
- Stochastic Oscillator
- TLSI 61.87
- MERC 45.14
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.